MedicarePartD.guide

A non-government resource built from CMS public data

Skyrizi on Horizon Medicare Blue Rx Enhanced (S5993-003)

risankizumab

Covered, with prior authorization required.

Tier 5 (specialty tier). Quantity limit of 16.8 per 365 days.

$2,852.97
Patient pays / month, after deductible
$2,992.97
Patient pays / month, before the $200.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

SKYRIZI Kit at a preferred retail pharmacy, from the plan's negotiated price of $9,509.89 for a month. Other covered strengths are listed below.

Prior authRequired on all 4 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 4 covered strengths and forms
FormTierPatient pays / monthLimits
SKYRIZI 150 mg/mL Injection5$3,323.34PA · 6 per 365 days
SKYRIZI Kit5$3,699.67PA · 8.4 per 365 days
SKYRIZI Kit5$2,852.97PA · 16.8 per 365 days
SKYRIZI 150 mg/mL Injection5$3,236.22PA · 6 per 365 days

Other IL-17 and IL-23 biologics on this plan

Verify with the plan before prescribing or filling. Member services: (800)391-1906. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5993-003